🔎 Trials Near Me

홈 › 췌장암 › 매사추세츠

매사추세츠의 췌장암 임상 시험

췌장암 관련 연구 48개가 매사추세츠 내 여러 지역에서 참여자를 모집하고 있습니다.

매사추세츠의 도시

공식 연구 텍스트(영어)

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07491445

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  • Dana Farber Cancer Institute, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07621718

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute (DFCI), Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07252232

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Dana Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

  • Investigative Site US022, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07522073

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06445062

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • Massachusetts General Hospital - Main Campus, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07629960

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT06271291

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07349537

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0124, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07492680

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

  • Boston Children's Hospital, Boston
피험자 모집 중관찰 연구
17세 이하 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06651580

Resilience and Equity in Aging, Cancer, and Health (REACH)

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중
65세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT04674267

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Massachusetts General Hospital, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05372614

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Dana-Farber Cancer Institute - Chestnut Hill, Newton
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07090499

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07644559

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Dana-Farber Cancer Institute - Oncology Department, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06760819

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

  • Dana-Farber Cancer Institute, Brookline
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05245500

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Boston
피험자 모집 중1/2상
18세 ~ 130세 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT05417594

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07059884

Pancreatic Cancer Early Detection Consortium

  • Massachusetts General Hospital, Boston
  • Umass Memorial Medical Center, Worcester
피험자 모집 중관찰 연구건강한 지원자 환영
18세 ~ 90세 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT04970056

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

  • Dana-Farber/Massachusetts General Hospital, Inc, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT07300150

Integrated Cancer Repository for Cancer Research

  • Holyoke Medical Center, Holyoke
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, Boston
  • Research Site, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT06835569

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

  • Dana Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT04890613

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT06040541

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
피험자 모집 중초기 1상건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 5. 29. 업데이트됨 · NCT06122896

Video Education With Result Dependent dIsclosure

  • Dana Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT05225428

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Dana Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

  • Massachusetts General Hospital, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06239194

A Study of MGC028 in Participants With Advanced Solid Tumors

  • Mass General Brigham, Boston
  • Dana Farber/Harvard Cancer Center, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 27. 업데이트됨 · NCT06723236

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Massachusetts General Hospital, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT07020221

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

  • Beth Israel Deaconess Medical Center - Division of Hematology/Oncology, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 3. 업데이트됨 · NCT06850623

Prehab for Pancreatic Cancer Surgery

  • UMass Memorial Medical Center, Worester
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 3. 업데이트됨 · NCT07478185

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • Dana-Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 18. 업데이트됨 · NCT06244771

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

  • Massachusetts General Hospital, Boston
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 2. 27. 업데이트됨 · NCT04485286

Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial

  • Dana Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 2. 19. 업데이트됨 · NCT05356117

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

  • Ohio State University-Telemedicine, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 2. 17. 업데이트됨 · NCT06906562

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.